ASTRAZENECA DEAL OFF IF VACCINE FAILS TO GET FDA APPROVAL
Department of Health (DOH) secretary Francisco Duque III said the COVID-19 vaccine deal among the government , the private sector and AstraZeneca may be voided if the British drugmaker’s vaccine fails to get regulatory approval in the Philippines.
Duque emphasized that the tripartite agreement requires the candidate vaccine to undergo evaluation by vaccine experts and the Food and Drug Administration (FDA).
Asked whether the agreement will be voided if the vaccine fails DFA standards, Duque said: “Posible ‘yan, syempre dahil ibig sabihin may violation ng agreement.”
Health Undersecretary Maria Rosario Vergeire said the supply deal, secured by the private sector, was an “advanced commitment” to ensure the Philippines will get 2.6 million shots of the vaccine.
AstraZeneca’s vaccine, which is reportedly 70% effective against COVID-19 at its first half dose and 90% after the second full dose, is up for evaluation by the Philippine Vaccine Experts Panel and the Ethics Review Board.